Published in Telemedicine Law Weekly, January 13th, 2007
This trend article about Oxford Radcliffe Hospitals NHS Trust, U.K., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: The diagnostic accuracy of presentation ischaemia-modified albumin in this study does not support its use as an effective risk stratification tool for patients with chest pain in the emergency department.
Researchers in England had as their objectives "to investigate the diagnostic accuracy of presentation ischaemia-modified albumin (IMA), in addition to cardiac troponin I (TnI), as a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.